English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsWorldRussia to begin Phase III trials of second COVID-19 vaccine in November-December: Report

    Russia to begin Phase III trials of second COVID-19 vaccine in November-December: Report

    Early-stage clinical trials for the vaccine were completed on Wednesday.

    Reuters
    October 02, 2020 / 19:16 IST
    3 | NHS England in talks on rollout of potential COVID vaccine from December, says report: The National Health Service (NHS) is in talks with the British Medical Association (BMA) and others around mobilising the rollout of a potential COVID-19 vaccine from December, Pulse website for health professionals reported. >There is optimism around the first cohorts being given a vaccine in December but there is a 50/50 chance of the vaccine being available by that time, Pulse reported, citing a person close to the discussions.

    Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia's Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on October 2.

    Early-stage clinical trials for the vaccine were completed on Wednesday.

    Follow our full coverage of the coronavirus pandemic here.

    Reuters
    first published: Oct 2, 2020 07:15 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347